News Archives - HEPHAISTOS-Pharma

HEPHAISTOS secures €10.3 M to reach the clinical stage

May 16, 2024

HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a…

Bio-Spring Europe 2024

Frederic CAROFF will attend BIO Europe Spring in Barcelona

March 14, 2024

Our CEO, Frederic CAROFF will be attending BIO-Europe Spring 2024…

HEPHAISTOS-Pharma secures a €2 million seed round

January 23, 2024

HEPHAISTOS-Pharma secures a €2 million seed round with xista science…

HEPHAISTOS Laureate of the SANOFI Golden Ticket mRNA

December 12, 2023

🏆 We are pleased to announce that HEPHAISTOS-Pharma has…

EIC accelerator Grant Competition Winner

November 12, 2023

🏆 We are very proud to announce that we are…

iNov BPIFrance 2030 Competition Winner

January 16, 2023

🏆 We are very proud to announce that we are…

Orphan Drug Designation

September 1, 2022

The European Medicines Agency (EMA) has granted Orphan Drug Designation…

University Paris Saclay

January 17, 2019

HEPHAISTOS-Pharma was present at the Event organized by the University…

Come in we’re hiring

January 1, 2019

HEPHAISTOS is currently hiring a Preclinical Development Manager, please send…

European Grant

December 17, 2018

HEPHAISTOS-Pharma obtained a European Grant for its development program of…

Page 1
Page 2
Next